Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ChrE
    Junior Member
    • Feb 2013
    • 4

    #1

    NimbleGen SeqCap EZ Choice Library-preparation for the PGM

    Hello all.

    From a previous project, we have a 'NimbleGen SeqCap EZ Choice Library'-design that we would now like to use for a new project on our Ion Torrent PGM.
    I am very new to next-gen sequencing, but it looks like I should be able to prepare a library (fragmented to appropriate PGM-size, PGM-adapter ligated, nick translated, size selected, amplified, and purified) according to the PGM protocols and then do the capture following NimbleGens protocol, followed by template preparation and sequencing according to the PGM protocols. The main problem seems to be the differences in the oligos used, i.e. during the NimbleGen capture 'hybridization enhancing'-oligos are added to the mixture. Can anyone please explain to me in detail what these are, how they are designed and how I might create a set corresponding to the PGM-adapters used?

    Also, according to the NimbleGen protocol a ligation-mediated PCR is performed after the capture. Can't I just do a PGM-protocol amplification here and achieve the same or am I missing a point here?

    Any advice would be greatly appreciated. Thanks in advance.

    Best regards
    Christian
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #2
    "Hyb enhancing" oligos are blocking oligos that anneal to the adapter sequences of your library, to prevent one properly captured library fragment (on-target) from pulling down another via annealing in the adapter regions. This dramatically increases your on-target rate.

    In my experience with SureSelect, you should get >>70% on target if your design is sound, leaving out the blocking Oligos will net ~40% on-target.

    There is a Nimblegen document (easily googleable, but if you any find it, I'll post it), that describes the design of the hyb enhancing oligos for Illumina. One can likely use the same principles to design blocking oligos for the IT adapters.

    Alternatively, call Nimblegen. I would be surprised if they didnt have a canned PGM recommendation.

    Good luck!

    Comment

    • ChrE
      Junior Member
      • Feb 2013
      • 4

      #3
      Thanks for the quick answer and forgive my late reply.

      I didnt manage to find the mentioned paper but contacted NimbleGen directly. They confirmed that it should be possible to exchange their HE-oligos with PGM adapter-complementary oligos and achieve the same, so I will give it a try very soon :-)

      Comment

      • Mahmoud
        Junior Member
        • Mar 2013
        • 4

        #4
        please update us with you results, cuz I'm planning to do the same.

        Comment

        • sokram
          Junior Member
          • Feb 2012
          • 2

          #5
          SeqCap EZ on the Ion Torrent

          Dear all,

          I just found this on the internet, didn't have the time to read it all through but it seems that the hyb enhancing oligos sequences are in there.

          Cheers,
          Attached Files

          Comment

          • ChrE
            Junior Member
            • Feb 2013
            • 4

            #6
            Great, this is spot on!
            Thanks a lot!

            Do you know who created this?

            Best regards

            Comment

            • cheerioet
              Junior Member
              • May 2013
              • 4

              #7
              Originally posted by sokram View Post
              Dear all,

              I just found this on the internet, didn't have the time to read it all through but it seems that the hyb enhancing oligos sequences are in there.

              Cheers,
              Thanks for this information.

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                by SEQadmin2



                Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                ...
                10-14-2026, 09:55 AM
              • SEQadmin2
                New Genomics Technologies Take Aim at Long-Standing Limits
                by SEQadmin2


                Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                ...
                09-28-2026, 10:25 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 10-15-2026, 10:52 AM
              0 responses
              17 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-14-2026, 05:39 AM
              0 responses
              26 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-13-2026, 09:56 AM
              0 responses
              22 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-09-2026, 11:14 AM
              0 responses
              28 views
              0 reactions
              Last Post SEQadmin2  
              Working...